Tesla Inc., a leading innovator in electric vehicles, is under increasing legal scrutiny as two major product liability cases ...

Nancy Jean Reece Kermashek, of Bella Vista, AR, formerly of Atchison and Leavenworth, KS, went to her final resting place on ...

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, accelerating a push into experimental cardiovascular therapies.

Adeno-associated virus (AAV)–mediated gene therapy has emerged as a promising treatment for hemophilia B. Data on safety and durability from 13 years of follow-up in a cohort of patients who had ...

A research team has identified two novel genetic mechanisms for disease resistance in wheat, offering promising strategies to enhance resilience against powdery mildew and stripe rust. The discoveries ...

Health Gene editing could treat damage from 'irreversible' kidney disease Using CRISPR to correct the mutations behind polycystic kidney disease could counter some of the damage the condition ...

A team of doctors at the Children's Hospital of Philadelphia and Penn Medicine treated a baby with a gene editing technology customized for his rare disease for the first time ever.

A change to a single gene in the bacterium Yersinia pestis has enabled one of the world’s most notorious pathogens to survive for centuries.

After spending over 300 days at CHOP, KJ Muldoon has been released from the hospital after receiving personalized CRISPR gene editing therapy.

Intellia Therapeutics’ stock may have taken a hit in the wake of details of a grade 4 adverse event in a phase 3 trial, but analysts are keeping faith in the gene therapy’s wider safety profile.

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Readers respond to an article about gene editing and object to cuts in research funding. Also: The Covid vaccine; Senator John Fetterman.